These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31228268)

  • 41. A chimeric cyclic interferon-α2b peptide induces apoptosis by sequential activation of phosphatidylinositol 3-kinase, protein kinase Cδ and p38 MAP kinase.
    Blank VC; Bertucci L; Furmento VA; Peña C; Marino VJ; Roguin LP
    Exp Cell Res; 2013 Jun; 319(10):1471-81. PubMed ID: 23562842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Müllerian serous carcinomas: clinical divergence without immunophenotypic differences.
    Soslow RA; Slomovitz BM; Saqi A; Baergen RN; Caputo TA
    Gynecol Oncol; 2000 Dec; 79(3):430-7. PubMed ID: 11104615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased STAT1 expression by promoter methylation in squamous cell carcinogenesis.
    Xi S; Dyer KF; Kimak M; Zhang Q; Gooding WE; Chaillet JR; Chai RL; Ferrell RE; Zamboni B; Hunt J; Grandis JR
    J Natl Cancer Inst; 2006 Feb; 98(3):181-9. PubMed ID: 16449678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single cell phospho-specific flow cytometry can detect dynamic changes of phospho-Stat1 level in lung cancer cells.
    Lin CC; Huang WL; Su WP; Chen HH; Lai WW; Yan JJ; Su WC
    Cytometry A; 2010 Nov; 77(11):1008-19. PubMed ID: 20814891
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2).
    English DP; Bellone S; Cocco E; Bortolomai I; Pecorelli S; Lopez S; Silasi DA; Schwartz PE; Rutherford T; Santin AD
    Am J Obstet Gynecol; 2013 Nov; 209(5):465.e1-9. PubMed ID: 23891627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant Pelvic Radiation "Sandwiched" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial.
    Frimer M; Miller EM; Shankar V; Girda E; Mehta K; Smith HO; Kuo DYS; Goldberg GL; Einstein MH
    Int J Gynecol Cancer; 2018 Nov; 28(9):1781-1788. PubMed ID: 30371562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma.
    Kommoss F; Faruqi A; Gilks CB; Lamshang Leen S; Singh N; Wilkinson N; McCluggage WG
    Am J Surg Pathol; 2017 Feb; 41(2):161-170. PubMed ID: 27776011
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.
    Cocco E; Lopez S; Black J; Bellone S; Bonazzoli E; Predolini F; Ferrari F; Schwab CL; Menderes G; Zammataro L; Buza N; Hui P; Wong S; Zhao S; Bai Y; Rimm DL; Ratner E; Litkouhi B; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Br J Cancer; 2016 Jul; 115(3):303-11. PubMed ID: 27351214
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer].
    Shi L; Yu H; Zhang W; Li L; Wang Q
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells.
    Chen X; Pan L; Wei J; Zhang R; Yang X; Song J; Bai RY; Fu S; Pierson CR; Finlay JL; Li C; Lin J
    Sci Rep; 2021 Mar; 11(1):6517. PubMed ID: 33753770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.
    Menderes G; Clark M; Santin AD
    Discov Med; 2016 Apr; 21(116):293-303. PubMed ID: 27232515
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway.
    Chang WM; Chang YC; Yang YC; Lin SK; Chang PM; Hsiao M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):245. PubMed ID: 31182137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MLH1 enhances the sensitivity of human endometrial carcinoma cells to cisplatin by activating the MLH1/c-Abl apoptosis signaling pathway.
    Li Y; Zhang S; Wang Y; Peng J; Fang F; Yang X
    BMC Cancer; 2018 Dec; 18(1):1294. PubMed ID: 30594176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Cisplatin inhibits proliferation of cervical carcinoma cell line by up-regulating Stat1 expression].
    Lei RL; Xiao SS; Xue M
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):88-92. PubMed ID: 25613616
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
    Yoshida H; Teramae M; Yamauchi M; Fukuda T; Yasui T; Sumi T; Honda K; Ishiko O
    Anticancer Res; 2013 Apr; 33(4):1409-14. PubMed ID: 23564780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines.
    Bandolik JJ; Hamacher A; Schrenk C; Weishaupt R; Kassack MU
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
    Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
    Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo.
    Schwab CL; English DP; Roque DM; Bellone S; Lopez S; Cocco E; Nicoletti R; Rutherford TJ; Schwartz PE; Santin AD
    Gynecol Oncol; 2014 Oct; 135(1):142-8. PubMed ID: 25124161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unphosphorylated STAT1 promotes sarcoma development through repressing expression of Fas and bad and conferring apoptotic resistance.
    Zimmerman MA; Rahman NT; Yang D; Lahat G; Lazar AJ; Pollock RE; Lev D; Liu K
    Cancer Res; 2012 Sep; 72(18):4724-32. PubMed ID: 22805310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.